Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer
(MedPage Today) -- WASHINGTON -- Treatment with cretostimogene grenadenorepvec, an investigational intravesically delivered oncolytic immunotherapy, achieved high response rates in patients with high-risk non-muscle-invasive bladder cancer (NMIBC... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 1, 2023 Category: Hematology Source Type: news
New CT, MR scanners and AI top GE HealthCare highlights at RSNA 2023
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. CT In CT, GEHC shined the spotlight on its Revolution Ascend scanner, which was first introduced at ECR in March. With onsite detector upgrades, Ascend can be upgraded from a 20-mm coverage system for routine scanning to a 40-mm coverage system that delivers better low-contrast detectability, according to the vendor. The scanner also comes with True Enhance DL, an AI-based application that generates deep learning-based monochromatic-like images from a single-energy x-ray acquisition....
Source: AuntMinnie.com Headlines - December 1, 2023 Category: Radiology Authors: Erik L. Ridley Tags: RSNA 2023 Source Type: news
A certain kind of cancer treatment may cause new cancer in some patients, FDA warns
According to the Food and Drug Administration, a life-saving type of cancer treatment may sometimes cause cancer. On Tuesday, the FDA said it received 19 reports of new blood cancers in patients who got chimeric antigen receptor, or CAR, T-cell immunotherapies. CAR-T therapy was first approved in…#fda #healthcare #mediagroup #cnnnewsource (Source: Reuters: Health)
Source: Reuters: Health - December 1, 2023 Category: Consumer Health News Source Type: news
Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer
(MedPage Today) -- MedPage Today brought together three expert leaders in the field -- moderator Susana Campos, MD, from the Dana-Farber Cancer Institute in Boston, is joined by Richard Penson, MBBS, of Mass General Cancer Center at Massachusetts... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 30, 2023 Category: Hematology Source Type: news
Why ‘ Healthspan ’ May Be More Important Than Lifespan
In 2014, then-57-year-old bioethicist Dr. Ezekiel Emanuel wrote an infamous essay titled, “Why I Hope to Die at 75” for The Atlantic. His argument boiled down to this: it’s not worth living as long as humanly possible if those efforts yield extra decades defined by disease and poor health, which data suggest is the fate awaiting many people in the U.S.
Nearly a decade later, neither Emanuel’s mind nor the statistics have changed much. Emanuel still says he plans to stop most life-extending medical care once he reaches age 75, though he’s healthy enough that he expects to live longer natural...
Source: TIME: Health - November 30, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
Researchers at Stanford University Discover Gene Variant That Appears to Protect Individuals from Both Alzheimer ’s and Parkinson’s Disease
Study findings may lead to new clinical laboratory tests, as well as vaccines and immunotherapies for neurodegenerative diseases Research into the human genome continues to produce useful new insights. This time, a study led by researchers at Stanford University identified a genetic variation that is believed to help “slow or even stall” progression of neurodegenerative […]
The post Researchers at Stanford University Discover Gene Variant That Appears to Protect Individuals from Both Alzheimer’s and Parkinson’s Disease appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - November 29, 2023 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing Precision Medicine allele Alzheimer’s Association Alzheimer’s disease anatomic pathology cli Source Type: news
CAR-T, Lifesaving Cancer Treatment, May Sometimes Cause Cancer, FDA Says
The agency is looking into reports that some patients developed new blood cancers after receiving CAR-T treatments. (Source: NYT Health)
Source: NYT Health - November 29, 2023 Category: Consumer Health News Authors: Gina Kolata Tags: Food and Drug Administration Cancer Immunotherapy Blood Genetic Engineering Research Source Type: news
FDA Looking Into CAR T Therapies on Cancer Risk
The U.S. Food and Drug Administration is investigating certain CAR T cancer therapies based on reports that they might cause a type of white blood cell to become cancerous in patients who received the treatment. CAR T cell immunotherapies work by manipulating a patient’s own disease-fighting white… (Source: Reuters: Health)
Source: Reuters: Health - November 29, 2023 Category: Consumer Health News Source Type: news
FDA Investigates Secondary Cancers From CAR T-Cell Therapies FDA Investigates Secondary Cancers From CAR T-Cell Therapies
The FDA has determined that the risk for lymphoma and other T-cell cancers may apply to approved BCMA- and CD-19 –directed CAR T-cell immunotherapies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Allergy Relief In Sight: Immunotherapy For Allergic Conjunctivitis
Allergen immunotherapy has emerged as a promising treatment for managing allergic conjunctivitis. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 28, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Seeking A Solution: Probiotic-Guided CAR T Cells For Solid Tumors
Beyond yogurt ads and health supplements, probiotics could revitalize cell-based cancer immunotherapies such as CAR T therapy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 24, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma
(MedPage Today) -- Adding immunotherapy to neoadjuvant chemotherapy for resectable gastroesophageal cancer led to higher rates of disease downstaging and pathologic complete response (pCR), an exploratory analysis of a randomized trial showed... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 24, 2023 Category: Gastroenterology Source Type: news
Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care
(MedPage Today) -- A novel treatment that reprograms tumors to make them more responsive to immunotherapy showed promising activity in a preliminary clinical study of triple-negative breast cancer. (Roswell Park Comprehensive Cancer Center, Journal... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 18, 2023 Category: Hematology Source Type: news
Certain NSCLC Subgroups May Not Benefit From Immunotherapy Certain NSCLC Subgroups May Not Benefit From Immunotherapy
A comprehensive study exploring NSCLC subgroup responses to immunotherapy may help determine which patients are less likely to benefit from these agents.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 16, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
